RYTHM (RYM) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Operates a portfolio of hemp-derived THC products and licensed consumer brands, including beverages and edibles, distributed in the U.S. and Canada.
Brands include Señorita, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon's, and Good Green; products are sold online, through retail, and via licensing agreements.
Recently exited the extraction and cultivation equipment businesses to focus on consumer packaged goods and brand licensing.
Acquired key intellectual property assets and entered into licensing and shared services agreements with Green Thumb Industries and its subsidiaries.
Finished goods are manufactured by third-party co-manufacturers; distribution is expanding through agreements with various partners.
Financial performance and metrics
As of December 12, 2025, public float was approximately $63.9 million, with 1,363,742 shares held by non-affiliates at a reference price of $46.84 per share.
Outstanding common stock totaled 2,149,128 shares, with significant warrants, options, and convertible notes outstanding.
Issued $90 million in secured convertible notes in 2024 and 2025, with conversion prices ranging from $3.158 to $29.475 and interest rates of 10% per annum.
Qualifies as a smaller reporting company, providing reduced disclosure and compliance requirements.
Use of proceeds and capital allocation
Net proceeds from offerings will be used for working capital, general corporate purposes, and potentially for acquisitions or strategic investments.
No specific allocation of proceeds; management has broad discretion in application.
Pending use, proceeds will be invested in short-term, investment-grade instruments.
Latest events from RYTHM
- Shareholders will vote on issuing shares that could give Green Thumb Industries over 90% control.RYM
Proxy filing9 Jul 2026 - Shareholders will vote on a proposal that could give Green Thumb Industries over 90% control.RYM
Proxy filing29 Jun 2026 - All proposals passed as the company targets THC market growth with strong brands and zero debt.RYM
AGM 202616 Jun 2026 - Rising THC demand, regulatory shifts, and strong licensing revenue drive growth and market reach.RYM
Investor presentation16 Jun 2026 - Q1 2026 net income $19.9M, 78% margin, revenue $13.3M, Q2 outlook $22M, strong licensing growth.RYM
Q1 20265 May 2026 - Virtual meeting to elect directors, ratify auditor, and expand equity plan on June 16, 2026.RYM
Proxy filing27 Apr 2026 - Annual meeting to elect directors, ratify auditor, and expand equity plan; Green Thumb holds 50%.RYM
Proxy filing27 Apr 2026 - Q4 revenue up 164% with 75% gross margin; regulatory risks persist for hemp-derived THC.RYM
Q4 20253 Mar 2026 - Shelf registration enables up to $100M in securities for growth, with focus on hemp-derived brands.RYM
Registration Filing16 Dec 2025